{
  "id": 16473610,
  "title": "Billy Evans’ ‘Theranos 2.0’ startup has patents, investors, and a missing CTO—but no product",
  "url": "https://urgent.news/2026/10/25/billy-evans-theranos-2-0-startup-has-patents-investors-and-a-missing",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-25T12:05:00.000Z",
  "source": {
    "name": "Fortune",
    "slug": "fortune",
    "url": "https://fortune.com/2026/10/25/elizabeth-holmes-partner-billy-evans-haemanthus-blood-testing-startup-theranos/"
  },
  "original_language": "en",
  "account": "Billy Evans, a 34-year-old grandson of Evans Hotels founders, is the CEO of Haemanthus, an Austin-based startup that claims to use lasers to detect diseases in blood, saliva, and urine. After being featured in a recent documentary about his wife Elizabeth Holmes, attention has shifted to Evans and his company. Haemanthus has reportedly raised up to $20 million in funding, and holds at least one granted patent, but it currently lacks a commercial product or validated diagnostic results. The company's technology, Raman spectroscopy, is not novel, but Haemanthus claims its approach is fundamentally different from Theranos' methods. A patent related to the technology was granted in January 2025, and early employees, including the former CTO, worked together at Luminar Technologies, a lidar startup that went bankrupt in 2025. Evans, who met Holmes at a party in 2017, is not an employee or shareholder of Evans Hotels, and his LinkedIn profile has removed all jobs except Haemanthus. He and Holmes have two children. Haemanthus plans to start with veterinary testing before pursuing human applications, but the company has not yet launched a product or disclosed any independently validated diagnostic results.",
  "summary": "As You Can See Everything turns Billy Evans into the year’s most unlikely documentary villain, his Austin startup Haemanthus faces a simple question: What has it built?",
  "key_points": [
    "Haemanthus CEO Billy Evans 34, grandson of Evans Hotels founders",
    "Startup raises up to $20M, holds granted patent in Raman spectroscopy",
    "Lacks product, validated diagnostics; former CTO left for bankrupt lidar firm"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}